Live feed
Filing
SC 13G
SC 13G0001104659-20-021226·MERRIMACK PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Merrimack Pharmaceuticals Inc
Security class unavailable · CUSIP: 590328209
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 747,635
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-021226
- Form type
- SC 13G
- Filer
- MERRIMACK PHARMACEUTICALS INC
- CIK
- CIK 1274792
- Filed
- Feb 14, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership